BlackRock’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $320M | Buy |
6,899,990
+736,263
| +12% | +$26.5M | ﹤0.01% | 1519 |
|
|
2026
Q1 | $151M | Buy |
6,163,727
+5,973
| +0.1% | +$141K | ﹤0.01% | 1845 |
|
|
2025
Q4 | $153M | Buy |
6,157,754
+150,120
| +2% | +$3.99M | ﹤0.01% | 1855 |
|
|
2025
Q3 | $170M | Buy |
6,007,634
+12,234
| +0.2% | +$332K | ﹤0.01% | 1763 |
|
|
2025
Q2 | $149M | Sell |
5,995,400
-287,543
| -5% | -$8.1M | ﹤0.01% | 1796 |
|
|
2025
Q1 | $195M | Sell |
6,282,943
-151,025
| -2% | -$5.03M | ﹤0.01% | 1607 |
|
|
2024
Q4 | $203M | Buy |
6,433,968
+55,030
| +0.9% | +$2.61M | ﹤0.01% | 1666 |
|
|
2024
Q3 | $370M | Sell |
6,378,938
-2,207
| -0% | -$108K | 0.01% | 1282 |
|
|
2024
Q2 | $259M | Sell |
6,381,145
-151,147
| -2% | -$5.99M | 0.01% | 1442 |
|
|
2024
Q1 | $274M | Buy |
6,532,292
+34,217
| +0.5% | +$1.33M | 0.01% | 1438 |
|
|
2023
Q4 | $249M | Sell |
6,498,075
-30,420
| -0.5% | -$1.01M | 0.01% | 1506 |
|
|
2023
Q3 | $201M | Buy |
6,528,495
+14,581
| +0.2% | +$503K | 0.01% | 1543 |
|
|
2023
Q2 | $206M | Buy |
6,513,914
+220,653
| +4% | +$7.57M | 0.01% | 1557 |
|
|
2023
Q1 | $230M | Sell |
6,293,261
-221,179
| -3% | -$7.74M | 0.01% | 1445 |
|
|
2022
Q4 | $193M | Buy |
6,514,440
+366,474
| +6% | +$11.8M | 0.01% | 1556 |
|
|
2022
Q3 | $240M | Buy |
6,147,966
+220,243
| +4% | +$10.1M | 0.01% | 1339 |
|
|
2022
Q2 | $229M | Sell |
5,927,723
-59,030
| -1% | -$2.25M | 0.01% | 1425 |
|
|
2022
Q1 | $290M | Buy |
5,986,753
+26,245
| +0.4% | +$1.35M | 0.01% | 1382 |
|
|
2021
Q4 | $438M | Buy |
5,960,508
+93,156
| +2% | +$7.65M | 0.01% | 1131 |
|
|
2021
Q3 | $534M | Buy |
5,867,352
+2,466,670
| +73% | +$210M | 0.02% | 930 |
|
|
2021
Q2 | $214M | Buy |
3,400,682
+1,907,983
| +128% | +$70.5M | 0.01% | 1710 |
|
|
2021
Q1 | $40.4M | Buy |
1,492,699
+3,347
| +0.2% | +$80.5K | ﹤0.01% | 2759 |
|
|
2020
Q4 | $27.2M | Buy |
1,489,352
+22,131
| +2% | +$398K | ﹤0.01% | 2845 |
|
|
2020
Q3 | $26.3M | Buy |
1,467,221
+469,248
| +47% | +$8.1M | ﹤0.01% | 2703 |
|
|
2020
Q2 | $16.5M | Buy |
997,973
+120,895
| +14% | +$1.9M | ﹤0.01% | 2903 |
|
|
2020
Q1 | $11.3M | Buy |
877,078
+59,069
| +7% | +$964K | ﹤0.01% | 2929 |
|
|
2019
Q4 | $15.1M | Sell |
818,009
-993,142
| -55% | -$16.5M | ﹤0.01% | 3037 |
|
|
2019
Q3 | $31.9M | Buy |
1,811,151
+1,083,027
| +149% | +$18.5M | ﹤0.01% | 2548 |
|
|
2019
Q2 | $12.2M | Buy |
728,124
+361,766
| +99% | +$6.57M | ﹤0.01% | 3138 |
|
|
2019
Q1 | $6.71M | Buy |
366,358
+13,140
| +4% | +$252K | ﹤0.01% | 3301 |
|
|
2018
Q4 | $7.01M | Buy |
353,218
+28,411
| +9% | +$532K | ﹤0.01% | 3261 |
|
|
2018
Q3 | $7.17M | Sell |
324,807
-768,239
| -70% | -$16.2M | ﹤0.01% | 3380 |
|
|
2018
Q2 | $28.3M | Buy |
+1,093,046
| New | +$18.7M | ﹤0.01% | 2668 |
|
Other funds holding ASTH
3C
BlackRock's ASTH Position: Q2 2026 in Review
BlackRock increased its Astrana Health (ASTH) stake by 12% in Q2 2026, buying an estimated $26.5M and bringing the position to 6,899,990 shares worth $320M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
BlackRock first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $534M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- BlackRock held 6,899,990 shares of Astrana Health worth $320M as of Q2 2026.
- BlackRock bought 736,263 Astrana Health shares in Q2 2026, an estimated $26.5M.
- Astrana Health made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1519 holding.
- BlackRock first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- BlackRock's Astrana Health position peaked at $534M in Q3 2021.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.